AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 182 filers reported holding AXSOME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $726,000 | +44.6% | 10,760 | +74.6% | 0.00% | – |
Q4 2020 | $502,000 | -36.0% | 6,162 | -44.0% | 0.00% | -100.0% |
Q3 2020 | $784,000 | -73.8% | 10,999 | -78.3% | 0.00% | -75.0% |
Q1 2020 | $2,989,000 | -5.4% | 50,794 | +66.3% | 0.00% | +33.3% |
Q4 2019 | $3,158,000 | +400.5% | 30,550 | -2.1% | 0.00% | +200.0% |
Q3 2019 | $631,000 | -63.6% | 31,191 | -53.7% | 0.00% | -50.0% |
Q2 2019 | $1,735,000 | +146.4% | 67,373 | -46.4% | 0.00% | +100.0% |
Q4 2017 | $704,000 | +1.0% | 125,670 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $697,000 | -3.6% | 125,670 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $723,000 | +44.6% | 125,670 | -2.0% | 0.00% | – |
Q1 2017 | $500,000 | -32.7% | 128,200 | +16.5% | 0.00% | -100.0% |
Q4 2016 | $743,000 | -12.3% | 110,090 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $847,000 | -5.8% | 110,090 | -7.7% | 0.00% | 0.0% |
Q2 2016 | $899,000 | -12.3% | 119,240 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $1,025,000 | -4.9% | 119,240 | +1.8% | 0.00% | 0.0% |
Q4 2015 | $1,078,000 | – | 117,165 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |